Accordingly, a newly constructed protein degrader for IL-17A was found to be effective in ameliorating imiquimod-induced psoriasis, suggesting that macrophages could be responsible for this assembled IL-17A degradation [126]. This evidence concerns the gene IL17A and psoriasis.